Literature DB >> 20179993

Newly identified tumor-associated role of human Sharpin.

Jinyoung Jung1, Jin Man Kim, Byoungwoo Park, Yeongmi Cheon, Bogman Lee, Seung Ho Choo, Sang Seok Koh, Soojin Lee.   

Abstract

In order to discover previously unidentified cancer-associated genes, we analyzed genome-wide differences in gene expression between tumor biopsies and normal tissues. Among those differentially regulated genes, we identified Sharpin (Shank-associated RH domain-interacting protein) as a commonly up-regulated gene in multiple human cancer types. Although rat Sharpin is reported to interact with Shank1, a multidomain scaffold protein localized in postsynaptic densities, its exact roles are unknown. Whereas human Sharpin homologue was primarily localized in the cytosol of cultured cells, they were detected in both cytosol and nucleus of the cells from ovarian and liver cancer tissues using immunohistochemical staining. In addition, Chinese ovary hamster cells over-expressing Sharpin exhibited enhanced cancer-specific phenotypes in multiple in vitro tumor assays. Taken together, the results suggest that Sharpin is not an inert scaffold protein, but may play tumor-associated roles during cancer biogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179993     DOI: 10.1007/s11010-010-0413-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  13 in total

1.  Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development.

Authors:  S Lim; S Naisbitt; J Yoon; J I Hwang; P G Suh; M Sheng; E Kim
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

Review 2.  The use and analysis of microarray data.

Authors:  Atul Butte
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

Review 3.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

Review 4.  Organisation of G-protein-coupled receptor signalling complexes by scaffolding proteins.

Authors:  Hans-Jürgen Kreienkamp
Journal:  Curr Opin Pharmacol       Date:  2002-10       Impact factor: 5.547

Review 5.  The postsynaptic density.

Authors:  T M Boeckers
Journal:  Cell Tissue Res       Date:  2006-07-25       Impact factor: 5.249

Review 6.  Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

Authors:  P A Clarke; R te Poele; R Wooster; P Workman
Journal:  Biochem Pharmacol       Date:  2001-11-15       Impact factor: 5.858

7.  Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins.

Authors:  S Lim; C Sala; J Yoon; S Park; S Kuroda; M Sheng; E Kim
Journal:  Mol Cell Neurosci       Date:  2001-02       Impact factor: 4.314

8.  Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2).

Authors:  Soojin Lee; Jingu Gang; Sun Bok Jeon; Seung Ho Choo; Bogman Lee; Young-Gun Kim; Yang Soon Lee; Jinyoung Jung; Si Young Song; Sang Seok Koh
Journal:  Biochem Biophys Res Commun       Date:  2007-06-28       Impact factor: 3.575

9.  Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis.

Authors:  R E Seymour; M G Hasham; G A Cox; L D Shultz; H Hogenesch; D C Roopenian; J P Sundberg
Journal:  Genes Immun       Date:  2007-05-31       Impact factor: 2.676

Review 10.  ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease.

Authors:  Tobias M Boeckers; Jürgen Bockmann; Michael R Kreutz; Eckart D Gundelfinger
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

View more
  29 in total

1.  The Sharpin interactome reveals a role for Sharpin in lamellipodium formation via the Arp2/3 complex.

Authors:  Meraj H Khan; Siiri I Salomaa; Guillaume Jacquemet; Umar Butt; Mitro Miihkinen; Takahiro Deguchi; Elena Kremneva; Pekka Lappalainen; Martin J Humphries; Jeroen Pouwels
Journal:  J Cell Sci       Date:  2017-08-03       Impact factor: 5.285

2.  SHARPINing integrin inhibition.

Authors:  Mark D Bass
Journal:  Nat Cell Biol       Date:  2011-11-02       Impact factor: 28.824

Review 3.  Integrin inactivators: balancing cellular functions in vitro and in vivo.

Authors:  Daniel Bouvard; Jeroen Pouwels; Nicola De Franceschi; Johanna Ivaska
Journal:  Nat Rev Mol Cell Biol       Date:  2013-05-30       Impact factor: 94.444

4.  68Ga-DOTA-E[c(RGDfK)]2 PET Imaging of SHARPIN-Regulated Integrin Activity in Mice.

Authors:  Riikka Siitonen; Emilia Peuhu; Anu Autio; Heidi Liljenbäck; Elina Mattila; Olli Metsälä; Meeri Käkelä; Tiina Saanijoki; Ingrid Dijkgraaf; Sirpa Jalkanen; Johanna Ivaska; Anne Roivainen
Journal:  J Nucl Med       Date:  2019-03-08       Impact factor: 10.057

5.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.

Authors:  Fuminori Tokunaga; Tomoko Nakagawa; Masaki Nakahara; Yasushi Saeki; Masami Taniguchi; Shin-ichi Sakata; Keiji Tanaka; Hiroyasu Nakano; Kazuhiro Iwai
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

6.  SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.

Authors:  Jin Li; Yiming Lai; Yi Cao; Tao Du; Lexiang Zeng; Ganping Wang; Xianju Chen; Jieqing Chen; Yongsheng Yu; Simin Zhang; Yiming Zhang; Hai Huang; Zhenghui Guo
Journal:  Med Oncol       Date:  2015-01-01       Impact factor: 3.064

7.  Loss-of-function of SHARPIN causes an osteopenic phenotype in mice.

Authors:  Tian Xia; Yanhua Liang; Junrong Ma; Mi Li; Meng Gong; Xijie Yu
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

8.  The pathogenesis of chronic eosinophilic esophagitis in SHARPIN-deficient mice.

Authors:  Syu-Jhe Chien; Kathleen A Silva; Victoria E Kennedy; Harm HogenEsch; John P Sundberg
Journal:  Exp Mol Pathol       Date:  2015-08-29       Impact factor: 3.362

9.  Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC).

Authors:  Francisco Aguilar-Alonso; Amanda L Whiting; Ye Joon Kim; Federico Bernal
Journal:  Bioorg Med Chem       Date:  2017-12-05       Impact factor: 3.641

10.  SHARPIN is an endogenous inhibitor of β1-integrin activation.

Authors:  Juha K Rantala; Jeroen Pouwels; Teijo Pellinen; Stefan Veltel; Petra Laasola; Elina Mattila; Christopher S Potter; Ted Duffy; John P Sundberg; Olli Kallioniemi; Janet A Askari; Martin J Humphries; Maddy Parsons; Marko Salmi; Johanna Ivaska
Journal:  Nat Cell Biol       Date:  2011-09-25       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.